New campaign from Thermo Fisher Scientific puts a face on pharma manufacturing

10 Apr 2018

First Pharma Services brand campaign from Madras celebrates the unsung heroes who get life-saving drugs to market.

New advertising for the Thermo Fisher Scientific Pharma Services portfolio, which includes both the Patheon and Fisher Clinical Services brands, puts a face on end-to-end drug development and delivery by celebrating real employees who bring expertise and commitment to deliver life-saving drugs to market.

New campaign from Thermo Fisher Scientific puts a face on pharma manufacturing

The campaign, developed with the agency Madras, marks a bold shift for the CMDO away from traditional capabilities and capacity communication that are standard in the space. By putting real people front and center in an integrated digital and print communication program directed at prospective clients and investors, the new campaign brings heart to what had been a purely scientific category.

Artful photography brings to life the human ingenuity that sets Thermo Fisher’s Patheon and Fisher Clinical Services businesses apart. Although any CDMO can offer technology and capacity, true excellence is only possible when the right people are in the lab and in the plant to see opportunities and offer insights to overcome challenges.

The new campaign tells real stories of how Thermo Fisher’s employees make, solve and deliver for clients. And it always comes down to a combination of heart and science.

The campaign comprises three employee message pillars: “MADE WITH Process and Purpose,” “SOLVED WITH Chemistry & Conviction,” and “DELIVERED WITH Capacity & Compassion.” The stories are real-life depictions of employees’ prowess and passion.

Perhaps the even more compelling campaign message pillar is “MADE FOR Trials & Triumphs,” which recognizes the driving force behind every Thermo Fisher Pharma Services employee’s work effort: making life-saving medicines available for real patients, every day.

“We found that the Patheon and Fisher Clinical Services brands leadership comes down to human ingenuity and commitment, so we put a face on the people who make vital cures available,” said Bill Davaris, chief creative officer at Madras. “Their commitment is extraordinary. We visited a factory where they played a video of patients before they started work, like rallying for a big game, getting everyone motivated to make it right, and make it on time. So, we created ads to evoke this human difference.”

Industry ads debuted on 20 March at the DCAT conference in New York City, while mainstream advertising broke 30 March in USA Today and other publications.

“Patheon and Fisher Clinical Services are already recognized leaders in the pharmaceutical industry,” said Bridget Johnson, vice president of marketing, Thermo Fisher Scientific Pharma Services. “This new campaign celebrates the individuals who earned that leadership position, and who will continue to deliver unmatched value for our clients in the future.”

Read More

Related news

BIA Separations expands with new upstream processing facility

BIA Separations expands with new upstream processing facility

20 Sep 2018

Provides single source of expertise for scaled production of complex biologics for gene therapy and vaccines.

Read more 
Sanofi to refocus two global business units

Sanofi to refocus two global business units

19 Sep 2018

The new Primary Care and China & Emerging Markets global business units are expected to launch at the beginning of 2019.

Read more 
Experts warn trade and patent changes could increase healthcare cost by $100bn over next 5 years

Experts warn trade and patent changes could increase healthcare cost by $100bn over next 5 years

18 Sep 2018

China is harmonizing to ICH standards at feverish pace and will force poor quality manufacturers out of market.

Read more 
Recipharm connects to European Hub for serialisation compliance

Recipharm connects to European Hub for serialisation compliance

18 Sep 2018

Connection allows the marketing authorisation holders within the Recipharm Group to continue to supply medicines to patients post the EU FMD implementation date.

Read more 
Bosch to unveil new laboratory device for continuous manufacturing

Bosch to unveil new laboratory device for continuous manufacturing

18 Sep 2018

The Xelum R&D offers pharmaceutical manufacturers an ideal start to continuous OSD production.

Read more 
Partnership to deliver integrated, off-the-shelf biosimilar manufacturing solutions

Partnership to deliver integrated, off-the-shelf biosimilar manufacturing solutions

17 Sep 2018

Pall and Aetos to advance the market impact of biosimilars and deliver lower-priced, high-quality options to end users.

Read more 
Cambrex expands manufacturing footprint with acquisition

Cambrex expands manufacturing footprint with acquisition

16 Sep 2018

Completed acquisition adds formulation development and finished dosage manufacturing capabilities to Cambrex’s existing global API manufacturing network.

Read more 
NMPA approves fruquintinib capsules for metastatic colorectal cancer

NMPA approves fruquintinib capsules for metastatic colorectal cancer

13 Sep 2018

Fruquintinib - innovative medicine that has not previously been launched in China or internationally - provides a new therapeutic approach for metastatic colorectal cancer patients.

Read more 
Aptar Pharma to showcase an industry first

Aptar Pharma to showcase an industry first

12 Sep 2018

PureHale is a new portable drug delivery device designed for upper respiratory care.

Read more 
Novartis to divest the Sandoz US dermatology business and generic US oral solids portfolio

Novartis to divest the Sandoz US dermatology business and generic US oral solids portfolio

11 Sep 2018

The Sandoz US portfolios to be sold to Aurobindo include approximately 300 products, as well as additional development projects.

Read more